Your session is about to expire
← Back to Search
Senior Companion Program for Aging
N/A
Recruiting
Led By William N Evans, PhD
Research Sponsored by William Evans
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6- and 18-months after study enrollment
Awards & highlights
Study Summary
This trial examines the effectiveness of having a weekly companion visit seniors in their homes to help with things like meals, transportation, and socialization.
Who is the study for?
This trial is for seniors who are isolated, lack social support, or whose caregivers need a break. To join, they must be at least 21+ or 65+ years old depending on the agency's rules and need help to keep living at home safely. It's not for those under age limits or in unsafe home conditions.Check my eligibility
What is being tested?
The study tests if Senior Companion Programs (SCP), where volunteers visit and assist with tasks like meals and housekeeping, can improve well-being and help seniors live independently at home instead of moving to assisted facilities.See study design
What are the potential side effects?
Since this trial involves social support rather than medical treatment, there aren't typical side effects. However, participants may experience changes in mood or behavior due to increased social interaction.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6- and 18-months after study enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6- and 18-months after study enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Difference in mortality rates of between treatment and control groups
Difference in rates of self-reported independent living status between treatment and control groups
Difference in rates of self-reported life satisfaction between treatment and control groups
+1 moreOther outcome measures
Self-reported physical and mental health
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Senior CompanionExperimental Treatment1 Intervention
Receives a companion to socialize with them, help with daily tasks, etc.
Group II: ControlActive Control1 Intervention
Referred to other services available in the community
Find a Location
Who is running the clinical trial?
William EvansLead Sponsor
Health Association of Niagara County, Inc.UNKNOWN
Catholic Charities of Southeast MichiganUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am either 21+ or 65+ years old and my living situation qualifies me for services.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Senior Companion
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research endeavor currently looking for volunteers?
"Information on clinicaltrials.gov reveals that the trial is presently recruiting participants, with a launch date of May 2nd 2022 and a recent update occurring on May 25th 2022."
Answered by AI
What is the total sample size of this clinical trial?
"Indeed, clinicaltrials.gov verifies that this medical research is actively seeking out participants after being published on May 2nd 2022 and revised lastly on the 25th of said month. Approximately 1040 individuals need to be enrolled from a single site for the trial to commence."
Answered by AI
Share this study with friends
Copy Link
Messenger